This document presents the public consultation of WP5 HTA Core Model® for Rapid Relative Effectiveness Assessment of Pharmaceuticals.
The draft HTA Core Model® for Rapid Relative Effectiveness Assessment of Pharmaceutical under production by Work Package 5 Joint Action 1 was open for public consultation from 1 October 2012 to 30 November 2012.
Objectice of the Model
It is the objective of work package 5 (WP5) to develop HTA tools and methods for relative effectiveness assessment (REA) of pharmaceuticals. For this purpose the HTA Core Model® was adapted into a version that specifically aims at REA of pharmaceuticals: the HTA Core Model® for Rapid Relative Effectiveness Assessment of Pharmaceuticals.
Please find the document of public consultation at the bottom of this page.
You can also find the document of the model by following this link: HTA Core Model® for Rapid Relative Effectiveness Assessment of Pharmaceutical.
This document is part of the JA1 Final Technical Report as Deliverable “D3-3 WP5_5b_Comments_and_responses_PC__HTA_Core_Model_for_Rapid_REA”
NOTE: For the full Technical Report, please follow this link.
